Table 2.
Reason | n | % |
---|---|---|
None reported or unclear | 51 | 40 |
Informative termination∗ | 34 | 27 |
Patient accrual | 17 | 13 |
Company/business decision | 11 | 9 |
Principal investigator left | 5 | 4 |
Conduct problems† | 4 | 3 |
Regulatory issue‡ | 3 | 2 |
Funding issue | 2 | 2 |
Changes in standard of care and safety or efficacy findings.
Technical/logistical issues.
Issues with institutional review board or other regulatory body.